Literature DB >> 34324858

Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression.

Yasser A Khadrawy1, Eman N Hosny2, Merna Magdy3, Haitham S Mohammed3.   

Abstract

The antidepressant effect of curcumin-coated iron oxide nanoparticles (Cur-IONPs) was investigated in the current study using depression rat model induced by reserpine. IONPs were synthesized by curcumin as a reducing agent producing Cur-IONPs. Rats were divided into control, depression rat model, and depressed rats treated with Cur-IONPs. After treatment rat behavior was evaluated using forced swimming test (FST). Serotonin (5-HT), norepinephrine (NE), dopamine (DA), monoamine oxidase (MAO), acetylcholinesterase (AchE), Na+, K+, ATPase, lipid peroxidation (MDA), reduced glutathione (GSH), glutathione-s-transferase (GST) and nitric oxide (NO) were measured in the cortex and hippocampus. In depressed rats, FST showed increased immobilization time and reduced swimming time. This was associated with a significant decrease in 5-HT, NE, DA and GSH and a significant increase in MDA and NO levels and GST, MAO, AchE and Na+, K+, ATPase activities in the cortex and hippocampus. Treatment with Cur-NONPs for two weeks increased the swimming time reduced the immobility time, and elevated 5-HT, NE and DA levels. Cur-IONPs attenuated the oxidative stress induced by reserpine and restored the MAO, AchE and Na+, K+, ATPase. The present green method used curcumin in the IONPs synthesis and has several merits; obtaining nanoform of iron oxide, increasing the bioavailability of curcumin and reducing the oxidative stress induced by iron. The present antidepressant effect of Cur-IONPs could be attributed to the ability of Cur-IONPs to restore monoamine neurotransmitter levels by increasing their synthesis and reducing their metabolism. In addition, the antioxidant activity of curcumin prevented oxidative stress in the depressed rats.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cur-IONPs; Depression; Monoamine neurotransmitters; Oxidative stress; Rats

Mesh:

Substances:

Year:  2021        PMID: 34324858     DOI: 10.1016/j.ejphar.2021.174384

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Curcumin for attention-deficit-hyperactivity disorder: a systematic review and preliminary behavioral investigation.

Authors:  Lélia Lilianna Borges de Sousa Macedo; Flavia Tasmin Techera Antunes; Willyane de Andrade Alvarenga; Mara Cristina Carvalho Batista; Mayara Storel Beserra de Moura; Mariane Nunes Lima Farias; Emanuelle Sistherenn Caminski; Eliane Dallegrave; Ivana Grivicich; Alessandra Hübner de Souza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-08       Impact factor: 3.000

2.  Affective Antidepressant, Cytotoxic Activities, and Characterization of Phyto-Assisted Zinc Oxide Nanoparticles Synthesized Using Sanvitalia procumbens Aqueous Extract.

Authors:  Yasir Rashid; Ijaz Ahmad; Nisar Ahmad; Madeeha Aslam; Amal Alotaibi
Journal:  Biomed Res Int       Date:  2022-06-16       Impact factor: 3.246

3.  A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Role on glutamate Transporter Activity in Chronic Depression.

Authors:  Yesim Yeni; Zeynep Cakir; Ahmet Hacimuftuoglu; Ali Taghizadehghalehjoughi; Ufuk Okkay; Sidika Genc; Serkan Yildirim; Yavuz Selim Saglam; Daniela Calina; Aristidis Tsatsakis; Anca Oana Docea
Journal:  J Pers Med       Date:  2022-02-09

Review 4.  An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders.

Authors:  Nicolás Lamanna-Rama; Diego Romero-Miguel; Manuel Desco; Maria Luisa Soto-Montenegro
Journal:  Antioxidants (Basel)       Date:  2022-02-10

Review 5.  An Updated Narrative Mini-Review on the Microbiota Changes in Antenatal and Post-Partum Depression.

Authors:  Bogdan Doroftei; Ovidiu-Dumitru Ilie; Roxana Diaconu; Delia Hutanu; Irina Stoian; Ciprian Ilea
Journal:  Diagnostics (Basel)       Date:  2022-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.